Insurance - Specialty
Compare Stocks
2 / 10Stock Comparison
HIPO vs LMND
Revenue, margins, valuation, and 5-year total return — side by side.
Insurance - Property & Casualty
HIPO vs LMND — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Insurance - Specialty | Insurance - Property & Casualty |
| Market Cap | $713M | $4.07B |
| Revenue (TTM) | $480M | $821M |
| Net Income (TTM) | $113M | $-139M |
| Gross Margin | 40.5% | 47.6% |
| Operating Margin | 24.2% | -16.3% |
| Forward P/E | 114.1x | — |
| Total Debt | $52M | $182M |
| Cash & Equiv. | $250M | $385M |
HIPO vs LMND — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jan 21 | May 26 | Return |
|---|---|---|---|
| Hippo Holdings Inc. (HIPO) | 100 | 9.6 | -90.4% |
| Lemonade, Inc. (LMND) | 100 | 36.5 | -63.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: HIPO vs LMND
Each card shows where this stock fits in a portfolio — not just who wins on paper.
HIPO carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- beta 1.40
- Rev growth 25.9%, EPS growth 235.4%, 3Y rev CAGR 57.6%
- Lower volatility, beta 1.40, Low D/E 12.0%, current ratio 0.35x
LMND is the clearest fit if your priority is long-term compounding.
- -23.6% 10Y total return vs HIPO's -90.5%
- 40.2% revenue growth vs HIPO's 25.9%
- +74.9% vs HIPO's +14.0%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 40.2% revenue growth vs HIPO's 25.9% | |
| Value | Better valuation composite | |
| Quality / Margins | Combined ratio 0.9 vs LMND's 1.2 (lower = better underwriting) | |
| Stability / Safety | Beta 1.40 vs LMND's 2.75, lower leverage | |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | +74.9% vs HIPO's +14.0% | |
| Efficiency (ROA) | 6.0% ROA vs LMND's -7.4%, ROIC 22.8% vs -36.8% |
HIPO vs LMND — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
HIPO vs LMND — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
HIPO leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
LMND is the larger business by revenue, generating $821M annually — 1.7x HIPO's $480M. HIPO is the more profitable business, keeping 23.4% of every revenue dollar as net income compared to LMND's -16.9%. On growth, LMND holds the edge at +55.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $480M | $821M |
| EBITDAEarnings before interest/tax | $116M | -$121M |
| Net IncomeAfter-tax profit | $113M | -$139M |
| Free Cash FlowCash after capex | $50M | $20M |
| Gross MarginGross profit ÷ Revenue | +40.5% | +47.6% |
| Operating MarginEBIT ÷ Revenue | +24.2% | -16.3% |
| Net MarginNet income ÷ Revenue | +23.4% | -16.9% |
| FCF MarginFCF ÷ Revenue | +10.4% | +2.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | +10.2% | +55.0% |
| EPS Growth (YoY)Latest quarter vs prior year | +114.1% | +45.3% |
Valuation Metrics
HIPO leads this category, winning 2 of 3 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $713M | $4.1B |
| Enterprise ValueMkt cap + debt − cash | $515M | $3.9B |
| Trailing P/EPrice ÷ TTM EPS | 12.34x | -23.04x |
| Forward P/EPrice ÷ next-FY EPS est. | 114.13x | — |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 8.14x | — |
| Price / SalesMarket cap ÷ Revenue | 1.52x | 5.52x |
| Price / BookPrice ÷ Book value/share | 1.63x | 7.13x |
| Price / FCFMarket cap ÷ FCF | 78.35x | — |
Profitability & Efficiency
HIPO leads this category, winning 7 of 8 comparable metrics.
Profitability & Efficiency
HIPO delivers a 27.4% return on equity — every $100 of shareholder capital generates $27 in annual profit, vs $-27 for LMND. HIPO carries lower financial leverage with a 0.12x debt-to-equity ratio, signaling a more conservative balance sheet compared to LMND's 0.34x. On the Piotroski fundamental quality scale (0–9), HIPO scores 5/9 vs LMND's 4/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +27.4% | -26.5% |
| ROA (TTM)Return on assets | +6.0% | -7.4% |
| ROICReturn on invested capital | +22.8% | -36.8% |
| ROCEReturn on capital employed | +6.9% | -22.7% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 4 |
| Debt / EquityFinancial leverage | 0.12x | 0.34x |
| Net DebtTotal debt minus cash | -$198M | -$203M |
| Cash & Equiv.Liquid assets | $250M | $385M |
| Total DebtShort + long-term debt | $52M | $182M |
| Interest CoverageEBIT ÷ Interest expense | — | — |
Total Returns (Dividends Reinvested)
LMND leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in LMND five years ago would be worth $6,962 today (with dividends reinvested), compared to $1,107 for HIPO. Over the past 12 months, LMND leads with a +74.9% total return vs HIPO's +14.0%. The 3-year compound annual growth rate (CAGR) favors LMND at 48.3% vs HIPO's 14.0% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -8.6% | -30.2% |
| 1-Year ReturnPast 12 months | +14.0% | +74.9% |
| 3-Year ReturnCumulative with dividends | +48.1% | +226.0% |
| 5-Year ReturnCumulative with dividends | -88.9% | -30.4% |
| 10-Year ReturnCumulative with dividends | -90.5% | -23.6% |
| CAGR (3Y)Annualised 3-year return | +14.0% | +48.3% |
Risk & Volatility
HIPO leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
HIPO is the less volatile stock with a 1.40 beta — it tends to amplify market swings less than LMND's 2.75 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. HIPO currently trades 70.3% from its 52-week high vs LMND's 53.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.40x | 2.75x |
| 52-Week HighHighest price in past year | $38.98 | $99.90 |
| 52-Week LowLowest price in past year | $19.92 | $28.71 |
| % of 52W HighCurrent price vs 52-week peak | +70.3% | +53.1% |
| RSI (14)Momentum oscillator 0–100 | 55.2 | 41.9 |
| Avg Volume (50D)Average daily shares traded | 113K | 1.9M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Wall Street rates HIPO as "Buy" and LMND as "Buy". Consensus price targets imply 37.1% upside for LMND (target: $73) vs 3.6% for HIPO (target: $28).
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $28.38 | $72.67 |
| # AnalystsCovering analysts | 6 | 15 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | — | — |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +2.0% | 0.0% |
HIPO leads in 4 of 6 categories (Income & Cash Flow, Valuation Metrics). LMND leads in 1 (Total Returns).
HIPO vs LMND: Frequently Asked Questions
9 questions · data-driven answers · updated daily
01Is HIPO or LMND a better buy right now?
For growth investors, Lemonade, Inc.
(LMND) is the stronger pick with 40. 2% revenue growth year-over-year, versus 25. 9% for Hippo Holdings Inc. (HIPO). Hippo Holdings Inc. (HIPO) offers the better valuation at 12. 3x trailing P/E (114. 1x forward), making it the more compelling value choice. Analysts rate Hippo Holdings Inc. (HIPO) a "Buy" — based on 6 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — HIPO or LMND?
Over the past 5 years, Lemonade, Inc.
(LMND) delivered a total return of -30. 4%, compared to -88. 9% for Hippo Holdings Inc. (HIPO). Over 10 years, the gap is even starker: LMND returned -23. 6% versus HIPO's -90. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — HIPO or LMND?
By beta (market sensitivity over 5 years), Hippo Holdings Inc.
(HIPO) is the lower-risk stock at 1. 40β versus Lemonade, Inc. 's 2. 75β — meaning LMND is approximately 97% more volatile than HIPO relative to the S&P 500. On balance sheet safety, Hippo Holdings Inc. (HIPO) carries a lower debt/equity ratio of 12% versus 34% for Lemonade, Inc. — giving it more financial flexibility in a downturn.
04Which is growing faster — HIPO or LMND?
By revenue growth (latest reported year), Lemonade, Inc.
(LMND) is pulling ahead at 40. 2% versus 25. 9% for Hippo Holdings Inc. (HIPO). On earnings-per-share growth, the picture is similar: Hippo Holdings Inc. grew EPS 235. 4% year-over-year, compared to 19. 3% for Lemonade, Inc.. Over a 3-year CAGR, HIPO leads at 57. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — HIPO or LMND?
Hippo Holdings Inc.
(HIPO) is the more profitable company, earning 12. 3% net margin versus -22. 4% for Lemonade, Inc. — meaning it keeps 12. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HIPO leads at 13. 5% versus -21. 8% for LMND. At the gross margin level — before operating expenses — HIPO leads at 50. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is HIPO or LMND more undervalued right now?
Analyst consensus price targets imply the most upside for LMND: 37.
1% to $72. 67.
07Which pays a better dividend — HIPO or LMND?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
08Is HIPO or LMND better for a retirement portfolio?
For long-horizon retirement investors, Hippo Holdings Inc.
(HIPO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding. Lemonade, Inc. (LMND) carries a higher beta of 2. 75 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (HIPO: -90. 5%, LMND: -23. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between HIPO and LMND?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.